Polydex Pharmaceuticals Limited Financial Analysis ReviewSummaryPolydex Pharmaceuticals Limited (PPL) is a biotechnology company, engaged in the development and manufacture of products based on dextran for use in drug delivery and in therapeutic compounds with a variety of health care applications. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. Its product portfolio includes products derived from Dextran, a natural polysaccharide which serves as a slow-release agent that reduces toxicity and boosts efficacy. It is developing Ushercell, a contraceptive made from high molecular weight cellulose sulphate which give women an alternative to condoms or consistent hormonal oral prophylactic pills. Global Market Directs Financial Analysis Review is an essential source for data, analysis and insight into Polydex Pharmaceuticals Limited . It examines the companys business structure and operations, products and services. The report provides information regarding key data, details on key executives and the major locations and subsidiaries of the company. It also provides key financial ratios for the company.Scope The report includes key company information such as business description, products and services, and key suppliers and competitors. It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters. Ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy A quick one-stop-shop to understand the company. Get an in depth understanding of companys recent and historical financial performance. Get the latest metrics on companys performance. Support sales activities by understanding your customers businesses better Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
